Topics

Solid Biosciences Company Profile

04:46 EST 27th January 2020 | BioPortfolio


News Articles [893 Associated News Articles listed on BioPortfolio]

FDA Slaps Second Clinical Hold on Solid Biosciences’ DMD Gene Therapy Due to Adverse Event

In its announcement, Solid Biosciences said a patient in its second cohort who was dosed in October experienced a serious adverse event that was deemed related to the drug.

Adverse Event Concerns With Solid Biosciences' Candidate DMD Gene Therapy

The US FDA has for the second time placed a clinical hold on Solid Biosciences’ potential gene therapy for Duchenne...   

Solid Biosciences gene therapy trial put on hold by FDA

Solid Biosciences Inc said on Tuesday the U.S. Food and Drug Administration has put on hold a trial testing its gene therapy for a muscle-wasting disorder.

Solid Biosciences gene therapy trial put on hold for second time, shares slump

Solid Biosciences Inc said on Tuesday the U.S. Food and Drug Administration had put on hold a trial testing its gene therapy for a muscle-wasting disorder, the second halt by the health regulator, sen...

Solid Biosciences shares plummet as gene therapy trial halted again

Shares in Solid Biosciences Inc plunged 71% on Tuesday after a trial testing its gene therapy for a muscle-wasting disorder was halted for the second time in less than two years.

Solid Biosciences’ Duchenne gene therapy trial halted after patient suffers serious toxicity

The FDA has halted a clinical trial involving a Duchenne muscular dystrophy gene therapy from Solid Biosciences after a patient suffered serious kidney and blood-related injuries.

Solid Biosciences Phase I/II Study of its Investigational Duchenne Muscular Dystrophy Candidate SGT-001 Placed on Clinical Hold

CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) today provided a clinical update on SGT-001 and reported that the U.S. Food and Drug Administration (FDA)...

Solid Biosciences Looks Like An Obvious Sell

Drugs and Medications [41 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Citranatal harmony [mission pharmacal company]

CitraNatal Harmony Rx Prenatal Vitamin Gel Cap

Citranatal harmony [mission pharmacal company]

CitraNatalHarmony Rx Prenatal Vitamin Gel Cap

Citranatal harmony [mission pharmacal company]

CitraNatal Harmony Rx Prenatal Vitamin Gel Cap

PubMed Articles [883 Associated PubMed Articles listed on BioPortfolio]

Heineken, Tsuchiya and Aris on the Mathematical Status of the Pseudo-steady State Hypothesis: a Classic from Volume 1 of Mathematical Biosciences.

Volume 1, Issue 1 of Mathematical Biosciences was the venue for a now-classic paper on the application of singular perturbation theory in enzyme kinetics, "On the mathematical status of the pseudo-ste...

Prognostic impact of solid-part tumour volume doubling time in patients with radiological part-solid or solid lung cancer.

The measurement of part-solid and whole tumour sizes in patients with non-small-cell lung cancer (NSCLC) using computed tomography (CT) has been widely accepted for assessing clinical outcomes. Althou...

Is Early Chemical Thromboprophylaxis in Patients with Solid Organ Injury a Solid Decision?

The optimal time to initiate chemical thromboprophylaxis (CTP) in patients who have undergone non-operative management (NOM) of blunt solid organ injuries remains controversial. The aim of our study w...

Preparation and Characterization of Sulfonated Magnetic SiO Microspheres as the Solid Acid Catalysts for Esterification.

The sulfonated magnetic SiO microsphere solid acid catalysts were prepared by the impregnation and grafting methods with iron oxide magnetic nanoparticles (FeO MNPs) as the magnetic cores. The catalyt...

Feasibility of synthesizing γ-Glu-Gln using high solid concentrations and glutaminase from Bacillus amyloliquefaciens as the catalyst.

Effects of using high solid concentrations on the synthesis of γ-[Glu]-Gln catalyzed by glutaminase from Bacillus amyloliquefaciens were examined in this study. An increment in solid concentration fr...

Clinical Trials [3081 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer

The drug for this submission is Hope Biosciences' allogeneic, first blood relative, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSCs) for the treatment of a single patien...

Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Parkinson's Disease

The drug for this submission is Hope Biosciences' autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC's) for the treatment of a single patient with Parkinson's Di...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Companies [841 Associated Companies listed on BioPortfolio]

Solid GT

Solid GT, a subsidiary of Solid Biosciences, is a gene therapy platform focused on developing novel, disease-modifying therapeutics for Duchenne muscular dystrophy. The companyâ...

Solid Biosciences

Nanospectra Biosciences, Inc.

Nanospectra Biosciences has an exclusive license to a new class of materials developed at Rice University, AuroShellâ„¢ microparticles (originally called nanoshells). While there are numerous ther...

Solid Dosage Training, Inc.

Solid Dosage Training is a California Corporation offering both introductory and single subject seminars on 26 different solid dosage manufacturing topics. We also lecture with the Center for Professi...

SOLID Datasystems, Inc.

SOLID Datasystems, Inc. pharmacy information systems are used by a wide range of pharmacies to fill millions of prescriptions per year. Explore our site to find out how SOLID/Rx and SOLID/POS can ben...

More Information about "Solid Biosciences" on BioPortfolio

We have published hundreds of Solid Biosciences news stories on BioPortfolio along with dozens of Solid Biosciences Clinical Trials and PubMed Articles about Solid Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solid Biosciences Companies in our database. You can also find out about relevant Solid Biosciences Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record